First human trial of Gene-Edited lung cells for rare breathing disorder

This study tests a new treatment for hereditary pulmonary alveolar proteinosis (hPAP), a rare lung disease where breathing becomes difficult. The therapy involves taking a patient's own lung cells, adding a working gene, and putting them back into the lungs. Only 3 people will join this early-phase trial to check safety and how well the body tolerates the treatment.